Bush, Karen
Article History
First Online: 20 October 2015
Competing interests
: K.B. receives retirement compensation from Johnson & Johnson, Pfizer and Bristol-Myers Squibb. She has received research funding from Cubist Pharmaceuticals, Forest Laboratories, AstraZeneca, Tetraphase and Achaogen.